Wockhardt – A story with twist and turn

Mr Khorakiwala today in interview with ET Now mentioned that Wockhardt’s US business went down from $500M to $150M due to US FDA ban on Waluj and Chikhalthana plant. He also mentioned that Wockhardt has completed all the pending action items like responding to minor issues raised by US FDA during their plant visits. So now it is only question of time when they should receive approvals.

So this makes a perfect case of ” Low Risk, High Uncertainty Business” as defined by acclaimed investor Mohnish Pabrai in his book “The Dhandho Investor”

I am adding more on every dip.

Please see the complete interview in the video in the attached link –

Disc – invested for more than one year and intend to hold for long term